OCT 01, 2015 10:30 AM PDT

How the diagnosis of melanoma is made: clinical detection/recognition and histologic/genetic assessment

Speakers
  • Director of Dermatopathology (Dermatology), Associate Professor, Dermatology & Pathology, University of Colorado School of Medicine
    Biography
      Whitney A. High, MD, MEng, a native of Colorado, is the Director of the laboratory, and he is board-certified in Dermatology and Dermatopathology. He also has certification in Tropical Medicine & Hygiene. After practicing as a chemical engineer in industry, Dr. High returned to medical school to receive his medical degree from the Mayo Clinic School of Medicine in 2000. Dr. High completed his dermatology residency training at University of Texas Southwestern Medical Center in 2004, serving as Chief Resident, and his dermatopathology fellowship at the University of Colorado in Denver in 2005. He has also studied tropical medicine in Central and South America.

      Dr. High is appointed to the Departments of Dermatology & Pathology at the University of Colorado, and the Department of Chemistry at the Colorado School of Mines. He serves as the only dermatologist on faculty at the Denver STD/HIV Training Center, a clinic sponsored by the Centers for Disease Control (CDC). Dr. High also has a degree in law from the University of Denver.

      Dr. High has authored 2 textbooks, 12 chapters and more than 40 medical papers. He currently serves as one of the youngest editors of the Journal of the American Academy of Dermatology, and he is an editor/editorial board member of other medical journals.

    Abstract:

    The assessment of pigmented lesions is a difficult area of dermatology and dermatopathology.  Melanoma is the leading cause of cancer in woman age 25-29 years, yet it is also a leading cause of medicolegal suits against pathologists.  Much of the assessment of melanoma is subjective, and as of 2015, we do not yet have a singular diagnostic tool for melanoma, in routine use, that has greater than about 90% sensitivity.  In my short primer, in introductory fashion, we will discuss how the diagnosis of melanoma is rendered on clinical and histologic grounds. 
     


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    MAR 26, 2019 02:00 PM PDT
    C.E. CREDITS
    MAR 26, 2019 02:00 PM PDT
    DATE:  March 26, 2019TIME:  2:00pm PDT, 5:00pm EDT  Prostate cancer is the second most common form of cancer in males, affecting one in eight men by the time t...
    Loading Comments...
    Show Resources